Disease: Asthma in Children

    What is asthma in children?

    Asthma is a chronic inflammatory disorder of the airways, characterized by recurrent, reversible, airway obstruction. Airway inflammation leads to airway hyperreactivity, which causes the airways to narrow in response to various stimuli, including allergens, exercise, and cold air.

    How common is asthma in children?

    Asthma is the most common chronic disease of childhood. The prevalence of asthma is increasing. This is also the case with other allergy conditions, including eczema (atopic dermatitis), hay fever (allergic rhinitis), and food allergies. According to recent CDC data, asthma affects approximately 8.5% of the pediatric population in the U.S., or more than 7 million children. Asthma accounts for more school absences and more hospitalizations than any other chronic condition in this country.

    What are the signs and symptoms of asthma in children?

    The most common symptoms of childhood asthma are coughing and wheezing.

    1. Coughing is typically non-productive and can frequently be the only symptom. When it is the only symptom, this is termed cough-variant asthma.
    2. Wheezing is a high-pitched whistling sound produced by turbulent airflow through narrowed airways.

    Other common symptoms include:

    1. Difficulty breathing
    2. Chest tightness
    3. Poor exercise endurance

    Symptoms are often worse with exertion or during the night. Night cough is also common. Symptoms are also typically exacerbated by viral upper respiratory infections, and these viral symptoms can linger for weeks in children with asthma, whereas age-controlled counterparts tend to recover much sooner. Symptoms can also have a seasonal variation, which can be due to environmental allergies. Tobacco smoke commonly aggravates symptoms, and secondhand tobacco smoke is not only a risk factor for developing childhood asthma, but also complicates asthma control. Children with asthma often have a history of recurrent bronchitis or even a recurrent croup-like cough.

    The physical exam in asthma is often completely normal. Occasionally, wheezing is present. In an asthma exacerbation, the respiratory rate increases, the heart rate increases, and children can look as if breathing is much more difficult. They may require accessory muscles to breath, and retractions of the chest wall adjacent to the ribs are common. Younger children may become lethargic and less interested in feeding. It is important to note that blood oxygen levels typically remain fairly normal even in the midst of a significant asthma exacerbation.

    How is asthma in children diagnosed?

    The diagnosis of asthma in children is often a purely clinical diagnosis. A typical history is a child with a family history of asthma and allergies who experiences coughing and difficulty breathing when playing with friends and/or who experiences frequent bouts of bronchitis or prolonged respiratory infections. Improvement with a trial of asthma medications essentially confirms the diagnosis of asthma.

    If the child is old enough, they may undergo testing to aid in the diagnosis of asthma. Spirometry is a breathing test to measure lung function and children can generally start performing proper technique for this testing around 5 years of age. Another test is exhaled nitric oxide (FeNO), which is a marker for airway inflammation, and this test may also be performed starting around 5 years of age. In younger children who cannot perform proper technique for lung function testing, impulse oscillometry is used to measure airway resistance. It should be noted, however, that this is a fairly involved test and it is rarely ordered in the diagnosis of pediatric asthma. The vast majority of younger children are diagnosed based on history alone.

    Other objective measures to help in the diagnosis of pediatric asthma include using a peak flow meter, which can help to estimate lung function. Sometimes, testing for airway hyperresponsiveness (methacholine or mannitol challenge) can help diagnosis asthma, again in older children capable of performing proper technique. Chest X-rays can sometimes be helpful to aid in the diagnosis of asthma. They may show hyperinflation, but are often completely normal. Allergy testing can also be helpful in diagnosis, since the risk of asthma is higher in children with sensitizations to common environmental aeroallergens. It is very important to recognize that a child can have poorly-controlled asthma despite completely normal lung function. Therefore, normal lung function does not preclude the diagnosis of asthma if a physician's clinical suspicion is high.

    What is the treatment for asthma in children?

    The goals for the treatment of asthma in children are to

    1. adequately control symptoms;
    2. minimize the risk of future exacerbations;
    3. maintain normal lung function;
    4. maintain normal activity levels; and
    5. use the least amount of medication possible with the least amount of potential side effects.

    Inhaled corticosteroids (cortisone medication) are the most effective anti-inflammatory agents available for the chronic treatment of asthma and are generally first-line therapy per most asthma guidelines. It is well recognized that inhaled corticosteroids are very effective in decreasing the risk of asthma exacerbations. Furthermore, the combination of a long-acting bronchodilator and an inhaled corticosteroid has a significant additional beneficial effect on improving asthma control.

    A complete list of commonly used asthma medications is as follows:

    1. Short-acting bronchodilators provide quick relief and are used for exercise-induced symptoms (for example, albuterol [Proventil, Ventolin, ProAir, Maxair, Xopenex]).
    2. Inhaled steroids are first-line anti-inflammatory therapy (for example, budesonide, fluticasone, beclomethasone, mometasone, ciclesonide).
    3. Long-acting bronchodilators can be added to inhaled corticosteroids as additive therapy (for example, salmeterol, formoterol).
    4. Leukotriene modifiers can also serve as anti-inflammatory agents (for example, montelukast, zafirlukast).
    5. Anticholinergic agents can help decrease sputum production (for example, ipratropium, tiotropium).
    6. Anti-IgE therapy can be used in adolescents with allergic asthma (for example, omalizumab).
    7. Chromones stabilize mast cells (allergic cells) but are rarely used in clinical practice (for example, cromolyn, nedocromil).
    8. Theophylline also helps with bronchodilation (opening the airways) but again is rarely used in clinical practice due to an unfavorable side effect profile.
    9. Systemic steroids are potent anti-inflammatory agents that are routinely used to treat asthma exacerbations but pose numerous unwanted side effects if used repeatedly or chronically (for example, prednisone, prednisolone, methylprednisone, dexamethasone).
    10. Numerous other monoclonal antibodies are being currently studied but none are currently commercially available for routine therapy of asthma.

    There is often concern about potential long-term side effects for even inhaled corticosteroids. Numerous studies have repeatedly shown that even long-term use of inhaled corticosteroids has very few if any sustained clinically significant side effects, including growth in children. However, the goal always remains to treat children (and adults) with the least amount of medication that is effective.

    Asthma medications can be administered via nebulized solution, which requires no technique and is very helpful in young children (often under 5 years of age). Around 5 years of age, children can transition to inhalers either with or without an aerochamber and/or a mask. It is important to note that if an individual has proper technique with an inhaler, the amount of medication deposition in the lungs is no different than with using a nebulized solution. When prescribing asthma medications, it is essential to provide the proper teaching on proper delivery technique.

    Although the vast majority of children with asthma are treated as outpatients, treatment of severe exacerbations can require management in the emergency department or inpatient hospitalization. These children typically require use of supplemental oxygen, early administration of systemic steroids, and frequent or even continuous administration of bronchodilators via a nebulized solution. Children at high risk for poor asthma outcomes should be referred to a specialist (pulmonologist or allergist). Children with the following factors may be at high risk:

    1. History of ICU admission or multiple hospitalizations for asthma
    2. History of multiple visits to the emergency department for asthma
    3. History of frequent use of systemic steroids for asthma
    4. Ongoing symptoms despite the use of appropriate medications
    5. Significant allergies contributing to poorly-controlled asthma

    How is asthma in children diagnosed?

    The diagnosis of asthma in children is often a purely clinical diagnosis. A typical history is a child with a family history of asthma and allergies who experiences coughing and difficulty breathing when playing with friends and/or who experiences frequent bouts of bronchitis or prolonged respiratory infections. Improvement with a trial of asthma medications essentially confirms the diagnosis of asthma.

    If the child is old enough, they may undergo testing to aid in the diagnosis of asthma. Spirometry is a breathing test to measure lung function and children can generally start performing proper technique for this testing around 5 years of age. Another test is exhaled nitric oxide (FeNO), which is a marker for airway inflammation, and this test may also be performed starting around 5 years of age. In younger children who cannot perform proper technique for lung function testing, impulse oscillometry is used to measure airway resistance. It should be noted, however, that this is a fairly involved test and it is rarely ordered in the diagnosis of pediatric asthma. The vast majority of younger children are diagnosed based on history alone.

    Other objective measures to help in the diagnosis of pediatric asthma include using a peak flow meter, which can help to estimate lung function. Sometimes, testing for airway hyperresponsiveness (methacholine or mannitol challenge) can help diagnosis asthma, again in older children capable of performing proper technique. Chest X-rays can sometimes be helpful to aid in the diagnosis of asthma. They may show hyperinflation, but are often completely normal. Allergy testing can also be helpful in diagnosis, since the risk of asthma is higher in children with sensitizations to common environmental aeroallergens. It is very important to recognize that a child can have poorly-controlled asthma despite completely normal lung function. Therefore, normal lung function does not preclude the diagnosis of asthma if a physician's clinical suspicion is high.

    What is the treatment for asthma in children?

    The goals for the treatment of asthma in children are to

    1. adequately control symptoms;
    2. minimize the risk of future exacerbations;
    3. maintain normal lung function;
    4. maintain normal activity levels; and
    5. use the least amount of medication possible with the least amount of potential side effects.

    Inhaled corticosteroids (cortisone medication) are the most effective anti-inflammatory agents available for the chronic treatment of asthma and are generally first-line therapy per most asthma guidelines. It is well recognized that inhaled corticosteroids are very effective in decreasing the risk of asthma exacerbations. Furthermore, the combination of a long-acting bronchodilator and an inhaled corticosteroid has a significant additional beneficial effect on improving asthma control.

    A complete list of commonly used asthma medications is as follows:

    1. Short-acting bronchodilators provide quick relief and are used for exercise-induced symptoms (for example, albuterol [Proventil, Ventolin, ProAir, Maxair, Xopenex]).
    2. Inhaled steroids are first-line anti-inflammatory therapy (for example, budesonide, fluticasone, beclomethasone, mometasone, ciclesonide).
    3. Long-acting bronchodilators can be added to inhaled corticosteroids as additive therapy (for example, salmeterol, formoterol).
    4. Leukotriene modifiers can also serve as anti-inflammatory agents (for example, montelukast, zafirlukast).
    5. Anticholinergic agents can help decrease sputum production (for example, ipratropium, tiotropium).
    6. Anti-IgE therapy can be used in adolescents with allergic asthma (for example, omalizumab).
    7. Chromones stabilize mast cells (allergic cells) but are rarely used in clinical practice (for example, cromolyn, nedocromil).
    8. Theophylline also helps with bronchodilation (opening the airways) but again is rarely used in clinical practice due to an unfavorable side effect profile.
    9. Systemic steroids are potent anti-inflammatory agents that are routinely used to treat asthma exacerbations but pose numerous unwanted side effects if used repeatedly or chronically (for example, prednisone, prednisolone, methylprednisone, dexamethasone).
    10. Numerous other monoclonal antibodies are being currently studied but none are currently commercially available for routine therapy of asthma.

    There is often concern about potential long-term side effects for even inhaled corticosteroids. Numerous studies have repeatedly shown that even long-term use of inhaled corticosteroids has very few if any sustained clinically significant side effects, including growth in children. However, the goal always remains to treat children (and adults) with the least amount of medication that is effective.

    Asthma medications can be administered via nebulized solution, which requires no technique and is very helpful in young children (often under 5 years of age). Around 5 years of age, children can transition to inhalers either with or without an aerochamber and/or a mask. It is important to note that if an individual has proper technique with an inhaler, the amount of medication deposition in the lungs is no different than with using a nebulized solution. When prescribing asthma medications, it is essential to provide the proper teaching on proper delivery technique.

    Although the vast majority of children with asthma are treated as outpatients, treatment of severe exacerbations can require management in the emergency department or inpatient hospitalization. These children typically require use of supplemental oxygen, early administration of systemic steroids, and frequent or even continuous administration of bronchodilators via a nebulized solution. Children at high risk for poor asthma outcomes should be referred to a specialist (pulmonologist or allergist). Children with the following factors may be at high risk:

    1. History of ICU admission or multiple hospitalizations for asthma
    2. History of multiple visits to the emergency department for asthma
    3. History of frequent use of systemic steroids for asthma
    4. Ongoing symptoms despite the use of appropriate medications
    5. Significant allergies contributing to poorly-controlled asthma

    Source: http://www.rxlist.com

    The goals for the treatment of asthma in children are to

    1. adequately control symptoms;
    2. minimize the risk of future exacerbations;
    3. maintain normal lung function;
    4. maintain normal activity levels; and
    5. use the least amount of medication possible with the least amount of potential side effects.

    Inhaled corticosteroids (cortisone medication) are the most effective anti-inflammatory agents available for the chronic treatment of asthma and are generally first-line therapy per most asthma guidelines. It is well recognized that inhaled corticosteroids are very effective in decreasing the risk of asthma exacerbations. Furthermore, the combination of a long-acting bronchodilator and an inhaled corticosteroid has a significant additional beneficial effect on improving asthma control.

    A complete list of commonly used asthma medications is as follows:

    1. Short-acting bronchodilators provide quick relief and are used for exercise-induced symptoms (for example, albuterol [Proventil, Ventolin, ProAir, Maxair, Xopenex]).
    2. Inhaled steroids are first-line anti-inflammatory therapy (for example, budesonide, fluticasone, beclomethasone, mometasone, ciclesonide).
    3. Long-acting bronchodilators can be added to inhaled corticosteroids as additive therapy (for example, salmeterol, formoterol).
    4. Leukotriene modifiers can also serve as anti-inflammatory agents (for example, montelukast, zafirlukast).
    5. Anticholinergic agents can help decrease sputum production (for example, ipratropium, tiotropium).
    6. Anti-IgE therapy can be used in adolescents with allergic asthma (for example, omalizumab).
    7. Chromones stabilize mast cells (allergic cells) but are rarely used in clinical practice (for example, cromolyn, nedocromil).
    8. Theophylline also helps with bronchodilation (opening the airways) but again is rarely used in clinical practice due to an unfavorable side effect profile.
    9. Systemic steroids are potent anti-inflammatory agents that are routinely used to treat asthma exacerbations but pose numerous unwanted side effects if used repeatedly or chronically (for example, prednisone, prednisolone, methylprednisone, dexamethasone).
    10. Numerous other monoclonal antibodies are being currently studied but none are currently commercially available for routine therapy of asthma.

    There is often concern about potential long-term side effects for even inhaled corticosteroids. Numerous studies have repeatedly shown that even long-term use of inhaled corticosteroids has very few if any sustained clinically significant side effects, including growth in children. However, the goal always remains to treat children (and adults) with the least amount of medication that is effective.

    Asthma medications can be administered via nebulized solution, which requires no technique and is very helpful in young children (often under 5 years of age). Around 5 years of age, children can transition to inhalers either with or without an aerochamber and/or a mask. It is important to note that if an individual has proper technique with an inhaler, the amount of medication deposition in the lungs is no different than with using a nebulized solution. When prescribing asthma medications, it is essential to provide the proper teaching on proper delivery technique.

    Although the vast majority of children with asthma are treated as outpatients, treatment of severe exacerbations can require management in the emergency department or inpatient hospitalization. These children typically require use of supplemental oxygen, early administration of systemic steroids, and frequent or even continuous administration of bronchodilators via a nebulized solution. Children at high risk for poor asthma outcomes should be referred to a specialist (pulmonologist or allergist). Children with the following factors may be at high risk:

    1. History of ICU admission or multiple hospitalizations for asthma
    2. History of multiple visits to the emergency department for asthma
    3. History of frequent use of systemic steroids for asthma
    4. Ongoing symptoms despite the use of appropriate medications
    5. Significant allergies contributing to poorly-controlled asthma

      Source: http://www.rxlist.com

    Health Services in

    Define Common Diseases

    Asthma Health Center helps you find information, definitaions and treatement options for most common diseases, sicknesses, illnesses and medical conditions. Find what diseases you have quick and now.